DSIP Research for Insomnia
An evidence-based overview of research examining DSIP in the context of insomnia. This page synthesizes findings from peer-reviewed literature.
Research Summary
Small human studies of intravenous DSIP reported mixed sleep outcomes. Early reports described improvement in some participants, while a later 16-person placebo-controlled study found weak objective signals, no subjective sleep-quality improvement, and concluded that short-term DSIP was unlikely to have major therapeutic benefit. The FDA's 2026 review found the evidence insufficient to establish effectiveness for chronic insomnia; it found no effectiveness study for the proposed subcutaneous route. The historical studies cannot establish benefit for current use.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.